Home > Insider Trading > Filing (0001209191-21-037144)

Filing Details

Accession Number:: 0001209191-21-037144
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-02 16:11:43
Reporting Period:: 2021-06-01

Accepted Time:: 2021-06-02 16:11:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1699382	Pmv Pharmaceuticals Inc.	PMVP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584759	A. Richard Heyman	C/O Pmv Pharmaceuticals, Inc. 8 Clarke Drive, Suite 3 Cranbury NJ 08512		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-01	1,950	$2.95	1,950	No	4	M	Indirect	See footnote
Common Stock	Disposition	2021-06-01	1,392	$32.15	558	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	553	$33.61	5	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	5	$34.67	0	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2021-06-01	975	$2.95	975	No	4	M	Indirect	See footnote
Common Stock	Disposition	2021-06-01	743	$32.16	232	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	230	$33.75	2	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	2	$34.67	0	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2021-06-01	975	$975.00	975	No	4	M	Indirect	See footnote
Common Stock	Disposition	2021-06-01	764	$32.15	211	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	209	$33.79	2	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-06-01	2	$34.67	0	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-06-01	1,950	$0.00	1,950	$2.95
Common Stock	Stock Option (right to buy)	Disposition	2021-06-01	975	$0.00	975	$2.95
Common Stock	Stock Option (right to buy)	Disposition	2021-06-01	975	$0.00	975	$2.95

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,901	2027-08-16	No	4	M	Indirect
7,951	2027-08-16	No	4	M	Indirect
7,951	2027-08-16	No	4	M	Indirect

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$2.95		2027-08-16	11,901	11,901	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-08-16	11,901	11,901	Direct

Footnotes

The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (9) and (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.055 to $33.875, inclusive.
The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.46, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.815, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive.
All of the shares subject to the option are vested and immediately exercisable.
The shares subject to the option are subject to an early exercise provision and are immediately exercisable. One forty-eighth of the shares subject to the option vested on September 17, 2017, and an additional one forty-eighth of the shares subject to the option shall vest each month thereafter.